← Back to Search

Behavioral Intervention

Monetary Incentives for Abstinence in Alcoholism

N/A

Waitlist Available

Research Sponsored by Mikhail N Koffarnus

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up a total of 12 assessment sessions spanning over a 66 week period

Awards & highlights

Study Summary

This trial will test whether adding monetary incentives for abstinence to standard treatment improves outcomes for people with alcohol dependence.

Who is the study for?

This trial is for individuals who are currently not drinking alcohol and have recently finished or are finishing an alcohol detox program at Carilion Clinic or University of Kentucky Healthcare. Participants must meet the criteria for alcohol use disorder as per DSM-V but cannot have a primary substance use disorder other than alcohol.Check my eligibility

What is being tested?

The study tests if adding monetary incentives for staying sober, verified through a remote breathalyzer connected to a smartphone app, can improve treatment outcomes and reduce relapse after inpatient detox compared to usual outpatient treatments.See study design

What are the potential side effects?

Since this trial involves behavioral interventions with no medications involved, there are no direct medical side effects. However, participants may experience stress or anxiety related to maintaining abstinence to receive monetary rewards.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ a total of 12 assessment sessions spanning over a 66 week period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~a total of 12 assessment sessions spanning over a 66 week period

This trial's timeline: 3 weeks for screening, Varies for treatment, and a total of 12 assessment sessions spanning over a 66 week period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pattern of abstinence from alcohol during intervention

Time to relapse

Treatment acceptability

Trial Design

5Treatment groups

Active Control

Placebo Group

Group I: No Intervention: Group E (no incentives)Active Control1 Intervention

Group E will have no monitoring intervention, they will only complete assessment sessions.

Group II: Active Comparator: Group A (Intensive incentives)Active Control1 Intervention

Group A will have the opportunity to earn payments based on the results of their breathalyzer screens. Participants will receive a compliance incentive per submitted sample regardless of the results, but will also have the opportunity to earn more incentives for providing negative results. For the first 3 weeks, these additional incentives will scale based on the number of consecutive days of sustained negative samples. For the remaining weeks incentives will be based on a randomized "prize" drawing.

Group III: Active Comparator: Group B (Prize-based incentives)Active Control1 Intervention

Group B will have the opportunity to earn payments based on the results of their breathalyzer screens. Participants will receive a compliance incentive per submitted sample regardless of the results, but will only have the opportunity to earn more incentives based on a randomized "prize" drawing if they submit a negative sample.

Group IV: Sham Comparator: Group C (Intensive incentives)Placebo Group1 Intervention

Group C serves as a direct control group to Group A and will follow the same incentive procedures, however participants will receive incentives regardless of the results of their samples.

Group V: Sham Comparator: Group D (Price-based incentives)Placebo Group1 Intervention

Group D serves as a direct control group to Group B and will follow the same incentive procedures, however participants will receive incentives regardless of the results of their samples.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH

799 Previous Clinical Trials

1,362,281 Total Patients Enrolled

422 Trials studying Alcoholism

984,978 Patients Enrolled for Alcoholism

Mikhail N KoffarnusLead Sponsor

2 Previous Clinical Trials

673 Total Patients Enrolled

1 Trials studying Alcoholism

200 Patients Enrolled for Alcoholism

Media Library

Contingency management (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03942770 — N/A

Alcoholism Research Study Groups: No Intervention: Group E (no incentives), Active Comparator: Group A (Intensive incentives), Active Comparator: Group B (Prize-based incentives), Sham Comparator: Group C (Intensive incentives), Sham Comparator: Group D (Price-based incentives)

Alcoholism Clinical Trial 2023: Contingency management Highlights & Side Effects. Trial Name: NCT03942770 — N/A

Contingency management (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03942770 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still open for the experimental research?

"Clinicaltrials.gov does not list this trial as currently recruiting patients, with the study first posted on July 15th 2019 and last updated October 13th 2022. Despite that, there are still 268 other trials actively seeking participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 2

Mikhail N Koffarnus 2019. "Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03942770.

All > Alcoholism